Unknown

Dataset Information

0

The tumour suppressor protein p53 can repress transcription of cyclin B.


ABSTRACT: The tumour suppressor protein p53 has functions in controlling the G(1)/S and G(2)/M transitions. Central regulators for progression from G(2) to mitosis are B-type cyclins complexed with cdc2 kinase. In mammals two cyclin B proteins are found, cyclin B1 and B2. We show that upon treatment of HepG2 cells with 5-fluorouracil or methotrexate, p53 levels increase while concentrations of cyclin B2 mRNA, measured by RT-PCR with the LightCycler system, are reduced. In DLD-1 colorectal adenocarcinoma cells (DLD-1-tet-off-p53) cyclin B1 and B2 mRNA levels drop after expression of wild-type p53 but not after induction of a DNA binding-deficient mutant of p53. Analysis of the cyclin B2 promoter reveals specific repression of this gene by p53. Transfection of wild-type p53 into SaOS-2 cells shuts off transcription from a cyclin B2 promoter-luciferase construct whereas a p53 mutant protein does not. The cyclin B2 promoter does not contain a consensus p53 binding site. Most of the p53-dependent transcriptional responsiveness resides in its 226 bp core promoter. Taken together with earlier observations on p53-dependent transcription of cyclin B1, our results suggest that one way of regulating G(2) arrest may be a reduction in cyclin B levels through p53-dependent transcriptional repression.

SUBMITTER: Krause K 

PROVIDER: S-EPMC113869 | biostudies-literature | 2000 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

The tumour suppressor protein p53 can repress transcription of cyclin B.

Krause K K   Wasner M M   Reinhard W W   Haugwitz U U   Dohna C L CL   Mössner J J   Engeland K K  

Nucleic acids research 20001101 22


The tumour suppressor protein p53 has functions in controlling the G(1)/S and G(2)/M transitions. Central regulators for progression from G(2) to mitosis are B-type cyclins complexed with cdc2 kinase. In mammals two cyclin B proteins are found, cyclin B1 and B2. We show that upon treatment of HepG2 cells with 5-fluorouracil or methotrexate, p53 levels increase while concentrations of cyclin B2 mRNA, measured by RT-PCR with the LightCycler system, are reduced. In DLD-1 colorectal adenocarcinoma c  ...[more]

Similar Datasets

| S-EPMC4235773 | biostudies-literature
| S-EPMC10734451 | biostudies-literature
2014-09-02 | GSE58712 | GEO
| S-EPMC1630404 | biostudies-literature
| S-EPMC548656 | biostudies-literature
| S-EPMC4590999 | biostudies-literature
| S-EPMC2735889 | biostudies-literature
| S-EPMC5007442 | biostudies-literature
| S-EPMC6907270 | biostudies-literature
| S-EPMC2632919 | biostudies-literature